Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Lp-PLA2-IN-3 | 2196245-16-4 | 99.9% | 467.85 g/mol | C20H13ClF3N3O3S | 5 MG
SDP

Catalog No. 5000262227
Encompass_Preferred

Lp-PLA2-IN-3 is a potent, orally bioavailable small-molecule inhibitor of lipoprotein-associated phospholipase A2 supplied for research use. It inhibits recombinant human Lp-PLA2 with an IC50 of 14 nM and is provided as a white to off-white solid suitable for in vitro and in vivo studies.

  • Potent inhibition of Lp-PLA2 with an IC50 of 14 nM.
  • High purity (99.9%) for reliable experimental results.
  • Orally bioavailable profile suitable for pharmacology studies.
  • Soluble at ≥ 250 mg/mL in DMSO and formulatable for in vivo dosing.
  • Stable as a powder when stored at -20°C for long-term storage.

Catalog No. 50-002-62227 Supplier Medchemexpress LLC Supplier No. HY1331495MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lp-PLA2-IN-3 is a potent, orally bioavailable small-molecule inhibitor of lipoprotein-associated phospholipase A2 supplied for research use. It inhibits recombinant human Lp-PLA2 with an IC50 of 14 nM and is provided as a white to off-white solid suitable for in vitro and in vivo studies.

  • Potent inhibition of Lp-PLA2 with an IC50 of 14 nM.
  • High purity (99.9%) for reliable experimental results.
  • Orally bioavailable profile suitable for pharmacology studies.
  • Soluble at ≥ 250 mg/mL in DMSO and formulatable for in vivo dosing.
  • Stable as a powder when stored at -20°C for long-term storage.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.